Severe refractory asthma: an update

by Reinier R.L. Wener, Elisabeth H. Bel
Published 2013-09-01

Adult-onset asthma: is it really different?

by Selma B. de Nijs, Lisette N. Venekamp, Elisabeth H. Bel
Published 2013-03-01

Author correction: Adult-onset asthma: is it really different?

by Selma B. de Nijs, Lisette N. Venekamp, Elisabeth H. Bel
Published 2013-06-01

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

by Charlene M. Prazma, Elisabeth H. Bel, Robert G. Price, Eric S. Bradford, Frank C. Albers, Steven W. Yancey
Published 2019-05-01

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial

by Akke-Nynke van der Meer, Kim de Jong, Aranka Hoekstra-Kuik, Elisabeth H. Bel, Anneke ten Brinke
Published 2021-08-01

“Take the active option” to support Healthy Lungs for Life

by Pippa Powell, Thierry Troosters, Frits M.E. Franssen, Martijn A. Spruit, Steve Sealy, Elisabeth H. Bel, Dan Smyth, Pieter S. Hiemstra
Published 2015-09-01

The impact of allergic rhinitis and asthma on human nasal and bronchial epithelial gene expression.

by Ariane H Wagener, Aeilko H Zwinderman, Silvia Luiten, Wytske J Fokkens, Elisabeth H Bel, Peter J Sterk, Cornelis M van Drunen
Published 2013-01-01

Controlo clínico e histopatológico da asma quando utilizada a hiperreactividade brônquica como um indicador adicional no tratamento da asma a longo prazo

by Jacob K. Sont, Luuk N.A. Willems, Elisabeth H. Bel, J Han, J.M. van Krieken, Jan P. Vandenbroucke, Peter J. Sterk
Published 2000-01-01

Response to mepolizumab treatment is sustained across 4-weekly dosing periods

by Ian D. Pavord, Eugene R. Bleecker, Roland Buhl, Pascal Chanez, Elisabeth H. Bel, Peter Howarth, Daniel J. Bratton, Frank C. Albers, Steven Yancey
Published 2020-09-01

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial

by Andrew Menzies-Gow, Jonathan Corren, Elisabeth H. Bel, Jorge Maspero, Liam G. Heaney, Mark Gurnell, Peter Wessman, Ubaldo J. Martin, Shahid Siddiqui, Esther Garcia Gil
Published 2019-09-01

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions

by Peter G. Gibson, Charlene M. Prazma, Geoffrey L. Chupp, Eric S. Bradford, Mark Forshag, Stephen A. Mallett, Steve W. Yancey, Steven G. Smith, Elisabeth H. Bel
Published 2021-06-01

Mannose binding lectin (MBL) levels predict lung function decline in severe asthma

by Ilonka. H. van Veen, Pieter. S. Hiemstra, Anneke ten Brinke, Anja Roos, Renate. M. Verhoosel, Jaap. K. Sont, Peter. J. Sterk, Klaus. F. Rabe, Elisabeth. H. Bel
Published 2006-12-01

Prospective observational study in patients with obstructive lung disease: NOVELTY design

by Helen K. Reddel, Maria Gerhardsson de Verdier, Alvar Agustí, Gary Anderson, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Richard J. Martin, Ian Pavord, David Price, Christina Keen, Asparuh Gardev, Stephen Rennard, Alecka Sveréus, Aruna T. Bansal, Lance Brannman, Niklas Karlsson, Javier Nuevo, Fredrik Nyberg, Simon S. Young, Jørgen Vestbo
Published 2019-02-01